A persistent, often progressive, lung disease, COPD results from chronic inflammation that leads to structural changes ...
The Progressive Fibrosing Interstitial Lung Disease (PF-ILD) market is currently valued at USD 4,742.2 Million in 2023 and is ...
The CEO of pharmaceuticals giant Roche has urged authorities to block the takeover of contract drug manufacturer Catalent by ...
Tracking patient response to DMARD therapy has the potential to improve remission, but multiple barriers must be overcome ...
An interim analysis from a long-term open-label extension study has underlined the clinical efficacy and safety of ...
The Roundup covers notable class action decisions from federal appellate courts and notable Supreme Court class action cert petitions.
CHICAGO -- An artificial intelligence (AI)-based study of home monitoring for neovascular age-related macular degeneration ...
At the forefront of poultry production, USPOULTRY's 2024 Live Production, Welfare and Biosecurity Seminar — held in Tucker, ...
The medicine, which Novo sells as Rybelsus, cut the risk of cardiovascular complications by 14% when added to standard ...
Hosted by Boehringer Ingelheim, the ‘CRM Summit’, an expert engagement forum, and the ‘IMETA CRM Discussions for EXperts (MEDEX CRM)’, a scientific expert meeting, brought together healthcare ...